Sofinnova Partners and Sofinnova Ventures think audiology is the next ophthalmology - a former backwater that has become an investable space.

Last week, the VCs came in as new investors in a CHF47.1 million ($50.7 million) series C round for Auris Medical AG, which is developing therapeutics for inner ear disorders.